Package 67457-436-50

Brand: doxorubicin hydrochloride

Generic: doxorubicin hydrochloride
NDC Package

Package Facts

Identity

Package NDC 67457-436-50
Digits Only 6745743650
Product NDC 67457-436
Product ID 67457-436_fa646028-c150-4d9b-80a8-8add851d684d
Description

1 VIAL in 1 CARTON (67457-436-50) / 25 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2014-02-27
Brand doxorubicin hydrochloride
Generic doxorubicin hydrochloride
Sample Package No

Linked Drug Pages (1)

Doxorubicin Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "fa646028-c150-4d9b-80a8-8add851d684d", "openfda": {"upc": ["0367457478104"], "unii": ["82F2G7BL4E"], "rxcui": ["1790095", "1790103"], "spl_set_id": ["5f71f79a-4f14-472d-b982-e28c3ce8f972"], "manufacturer_name": ["Mylan Institutional LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (67457-436-50)  / 25 mL in 1 VIAL", "package_ndc": "67457-436-50", "marketing_start_date": "20140227"}], "brand_name": "Doxorubicin Hydrochloride", "product_id": "67457-436_fa646028-c150-4d9b-80a8-8add851d684d", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Anthracycline Topoisomerase Inhibitor [EPC]", "Anthracyclines [CS]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "67457-436", "generic_name": "Doxorubicin Hydrochloride", "labeler_name": "Mylan Institutional LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Doxorubicin Hydrochloride", "active_ingredients": [{"name": "DOXORUBICIN HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "ANDA200170", "marketing_category": "ANDA", "marketing_start_date": "20140227", "listing_expiration_date": "20261231"}